NovaBay Pharmaceuticals Inc (NYSE American:NBY)

2.65
Delayed Data
As of 12:16pm ET
 +0.025 / +0.95%
Today’s Change
2.00
Today|||52-Week Range
5.00
-31.17%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 3.75. The median estimate represents a +79.25% increase from the last price of 2.65.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$4.2M
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.93%
 
 
 
 
 
 
Growthannually 56.25%
 
 
 
 
 
 

Sales

Growthquarterly 42.42%
 
 
 
 
 
 
Growthannually 7.10%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.